Notification of Policy Revisions Effective September 22, 2020 Posted July 21, 2020
Medical Policy | Revision |
Hematopoietic Cell Transplantation for Hodgkin Lymphoma "Notification" | Updated Description and Policy Guidelines sections. Under When Not Covered section: coverage for tandem autologous HCT changed to investigational from medically necessary. Medical Director review 7/2020. Reference added. Notification 7/21/2020 for effective date 9/22/2020. |